May 12, 2012 /24-7PressRelease / -one of the most serious complications of total knee replacement is the development of deep vein thrombosis, or DVT - the presence of one or more blood clots that partially or completely block a vein. These DVTs can eventually lead to a fatal pulmonary embolism.
The possibility of DVT after a total knee replacement is for any patient. There are some factors that were related to an increased risk, including:
-More than 40 years of age
-Estrogen
-Stroke
-Nephrotic syndrome
-Cancer
-Prolonged immobility
Thromboembolism previous
-L' Congestive heart failure
-The femoral vein Indwelling Catheter
-Inflammatory bowel disease
-L' obesity
-Varicose veins
-Smoking
-Hypertension
-Diabetes mellitus
-Myocardial infarction
DVT in popliteal vein (behind the knee) is worse than in a calf of the vein, but may pose a higher risk of pulmonary embolism.
Many methods of treatment to prevent the DVTs are available, including mechanical and pharmaceutical options.
Options of products pharmaceutical heparin low molecular weight, such as enoxaparin (Lovenox), and fondaparinux (Arixtra) demonstrated be effective in preventing DVTs after total knee replacement. Some medical literature recommends that the treatment for at least 14 days in patients without a history of DVTs and the continuation of the treatment for a total of 6 weeks in patients with a history of previous thrombo-Embolic events.
For more information about total knee replacement, deep vein thrombosis or pulmonary embolism, please contact Koskoff, Koskoff and Bieder at 1 800 366-4421, or use our online contact form.
Web site: http://www.koskoff.com/
---
Release news and press release distribution service provided by http://www.24-7pressrelease.com
# # #
Read more in - press releases:View the original article here
No comments:
Post a Comment